Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
about
Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center studyPrevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab.Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study.
P2860
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluation of risk of symptoma ...... s: a single-institution study.
@en
type
label
Evaluation of risk of symptoma ...... s: a single-institution study.
@en
prefLabel
Evaluation of risk of symptoma ...... s: a single-institution study.
@en
P2093
P2860
P50
P356
P1476
Evaluation of risk of symptoma ...... s: a single-institution study.
@en
P2093
F Pimpinelli
M L Dessanti
S Gumenyuk
P2860
P304
P356
10.1111/TID.12309
P577
2014-11-05T00:00:00Z